Neuroendocrine neuropeptides such as vasopressin, oxytocin, and neurotensin serve as neurohormones, and neurotransmitters in the mammalian brain. The expression of the genes which encode these peptides, and their receptors, in brain neurons is regulated by steroid hormones such as estrogen, corticosteroids, and testosterone. This laboratory has for several years attempted to understand the importance of this hormonal modulation in the function of these neuropeptide systems, has used them to understand the cellular and molecular events which mediate the effects of steroids on neurotransmitter gene transcription in brain neurons. Data gathered in neuroblastoma cells, in primary neuronal cultures, and in the rat and mouse brain in vivo suggests that estrogen acts not only through the """"""""classical"""""""" mechanism of action involving nuclear hormone receptor dimerization and binding to consensus hormone response elements, but also via """"""""cross-talk"""""""" with other protein kinase-dependent signal transduction pathways such as protein kinase A, and the mitogen activated protein kinases. The studies proposed in this renewal application will test the hypothesis that estrogenic regulation of neuropeptide gene expression in vitro and in vivo. They will also investigate the relative roles of estrogen receptor-subtypes (ERalpha and the newly identified ERbeta) in these responses involves a mix of """"""""classical"""""""" and protein kinase-dependent transcriptional actions. It is, thus, the combination of these effects which confer the dramatic effects of hormones such as estrogen on the brain involved in neuroendocrine regulation, reproductive behavior, as well as neurotropic effects in the developing and aging. The approach will involve identification of signal transduction cascades which respond to estrogen, determination of their ability to enhance transcription of neuropeptide/receptor promoter-reporter gene constructs in vitro, and profiling their sensitivity to estrogen receptor agonists and antagonists. Local implantation of ER agonists and antagonists, and pharmacologic agents which activate or inhibit the relevant signal transduction pathways will be used.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS020311-17
Application #
6187666
Study Section
Special Emphasis Panel (ZRG1-IFCN-2 (01))
Program Officer
Edwards, Emmeline
Project Start
1983-12-01
Project End
2004-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
17
Fiscal Year
2000
Total Cost
$252,160
Indirect Cost
Name
University of Washington
Department
Psychiatry
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wu, Wendy W; Bryant, Damani N; Dorsa, Daniel M et al. (2013) Ovarian hormone loss impairs excitatory synaptic transmission at hippocampal CA3-CA1 synapses. J Neurosci 33:16158-69
Bryant, D N; Dorsa, D M (2010) Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity. Neuroscience 170:1261-9
Matagne, Valerie; Mastronardi, Claudio; Shapiro, Robert A et al. (2009) Hypothalamic expression of Eap1 is not directly controlled by ovarian steroids. Endocrinology 150:1870-8
Sheldahl, L C; Shapiro, R A; Bryant, D N et al. (2008) Estrogen induces rapid translocation of estrogen receptor beta, but not estrogen receptor alpha, to the neuronal plasma membrane. Neuroscience 153:751-61
Marriott, L K; McGann-Gramling, K R; Hauss-Wegrzyniak, B et al. (2007) Brain infusion of lipopolysaccharide increases uterine growth as a function of estrogen replacement regimen: suppression of uterine estrogen receptor-alpha by constant, but not pulsed, estrogen replacement. Endocrinology 148:232-40
Marriott, L K; McGann-Gramling, K R; Hauss-Wegrzyniak, B et al. (2007) Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus. Endocrine 32:317-28
Mhyre, Andrew J; Shapiro, Robert A; Dorsa, Daniel M (2006) Estradiol reduces nonclassical transcription at cyclic adenosine 3',5'-monophosphate response elements in glioma cells expressing estrogen receptor alpha. Endocrinology 147:1796-804
Mhyre, A J; Dorsa, D M (2006) Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia. Neuroscience 138:851-8
Chartoff, Elena H; Szczypka, Mark S; Palmiter, Richard D et al. (2004) Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy. Brain Res 1022:71-80
Wade, Christian B; Dorsa, Daniel M (2003) Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 144:832-8

Showing the most recent 10 out of 100 publications